Stockscreener 앱 받기
11.49
4.33%
-0.52
시간 외 거래:
11.50
0.010
+0.09%
전일 마감가:
$12.01
열려 있는:
$11.77
하루 거래량:
1.68M
Relative Volume:
1.35
시가총액:
$895.19M
수익:
$1.53B
순이익/손실:
$40.23M
주가수익비율:
22.98
EPS:
0.5
순현금흐름:
$60.93M
1주 성능:
-27.87%
1개월 성능:
-22.36%
6개월 성능:
-31.81%
1년 성능:
-40.40%
1일 변동 폭
$11.08
$11.85
1주일 범위
$11.05
$15.85
52주 변동 폭
$11.05
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
명칭
Integra Lifesciences Holdings Corp
전화
(609) 275-0500
주소
1100 CAMPUS ROAD, PRINCETON, NJ
IART을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
11.49 | 935.48M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-31 | 업그레이드 | Argus | Hold → Buy |
| 2024-12-02 | 개시 | Morgan Stanley | Underweight |
| 2024-10-07 | 업그레이드 | BTIG Research | Sell → Neutral |
| 2024-07-30 | 다운그레이드 | BTIG Research | Neutral → Sell |
| 2024-07-30 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2024-05-07 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-12-05 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-11-14 | 개시 | CL King | Buy |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-07-12 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-08 | 다운그레이드 | Argus | Buy → Hold |
| 2023-05-24 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-07-25 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-04-13 | 다운그레이드 | Truist | Buy → Hold |
| 2021-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-09-15 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-27 | 개시 | Citigroup | Neutral |
| 2020-04-03 | 개시 | SunTrust | Buy |
| 2020-01-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2019-01-03 | 개시 | SunTrust | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-07 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-07-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2018-07-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Neutral |
| 2018-01-02 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-10-30 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2017-10-27 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-05-02 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-13 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2017-01-06 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2016-12-12 | 개시 | UBS | Buy |
모두보기
Integra Lifesciences Holdings Corp 주식(IART)의 최신 뉴스
Integra Lifesciences (IART) Sees Revised Analyst Ratings Today | IART Stock News - GuruFocus
Is Integra LifeSciences Holdings Corporation (IL3) stock a top pick for value investors2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
How Integra LifeSciences Holdings Corporation (IL3) stock responds to bond marketQuarterly Profit Review & Capital Efficiency Focused Strategies - newser.com
Published on: 2025-11-03 05:22:14 - newser.com
Does Integra LifeSciences Holdings Corporation show high probability of rebound2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Published on: 2025-11-02 20:58:58 - newser.com
Will Integra LifeSciences Holdings Corporation (IL3) stock profit from AI boomLong Setup & Free Growth Oriented Trading Recommendations - newser.com
Is Integra LifeSciences Holdings Corporation stock vulnerable to regulatory risksMarket Rally & Safe Entry Trade Reports - newser.com
Integra LifeSciences Holdings Corporation stock trend forecast2025 Key Highlights & Detailed Earnings Play Strategies - newser.com
Integra LifeSciences (IART): Deep Losses and Discounted Valuation Shape Sentiment Ahead of Earnings - Yahoo Finance
Integra LifeSciences (NASDAQ:IART) Price Target Cut to $11.00 by Analysts at Citigroup - MarketBeat
Integra LifeSciences Hits 52-Week Low at USD 11.05 Amidst Decline - Markets Mojo
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2025 Earnings Call Transcript - Insider Monkey
Integra LifeSciences (NASDAQ:IART) Hits New 52-Week LowHere's What Happened - MarketBeat
How buyback programs support Integra LifeSciences Holdings Corporation (IL3) stockIndex Update & Safe Swing Trade Setup Alerts - newser.com
Is Integra LifeSciences Holdings Corporation stock poised for growthWeekly Market Outlook & Weekly Stock Performance Updates - newser.com
Technical signs of recovery in Integra LifeSciences Holdings CorporationJuly 2025 Breakouts & Reliable Price Breakout Alerts - newser.com
Intraday pattern recognizer results for Integra LifeSciences Holdings CorporationOptions Play & Reliable Entry Point Trade Alerts - newser.com
Integra LifeSciences (NASDAQ:IART) Issues Earnings Results - MarketBeat
Integra LifeSciences (NASDAQ:IART) Trading Down 23.2%What's Next? - MarketBeat
Citigroup Maintains "Sell" Rating on Integra Lifesciences (IART) with Lowered Price Target | IART Stock News - GuruFocus
Integra LifeSciences Hits Day Low of $11.05 Amid Price Pressure - Markets Mojo
JP Morgan Raises Price Target for Integra Lifesciences (IART) to $13 | IART Stock News - GuruFocus
Integra LifeSciences (NASDAQ:IART) Releases Q4 2025 Earnings Guidance - MarketBeat
Does Integra LifeSciences Holdings Corporation qualify in momentum factor screeningJuly 2025 Highlights & Fast Moving Market Watchlists - newser.com
How to use Fibonacci retracement on Integra LifeSciences Holdings CorporationQuarterly Risk Review & Daily Chart Pattern Signal Reports - newser.com
Integra: Q3 Earnings Snapshot - Stamford Advocate
Is Integra LifeSciences Holdings Corporation stock undervalued vs historical averagesWeekly Market Outlook & Entry Point Confirmation Signals - newser.com
Will Integra LifeSciences Holdings Corporation stock deliver better than expected guidance - newser.com
Integra LifeSciences Holdings Corporation (IART) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Integra Lifesciences Holdings Corp (IART) Q3 2025 Earnings Call Highlights: Strong EPS Growth ... By GuruFocus - Investing.com Canada
Integra Lifesciences Holdings Corp (IART) Q3 2025 Earnings Call Highlights: Strong EPS Growth ... - Yahoo Finance
Integra LifeSciences Q3 revenue $402,062 amid $511,365 impairment YTD - Stock Titan
Integra Lifesciences Holdings Corp (IART) Q3 2025 Earnings Call - GuruFocus
Integra LifeSciences Drops After Cutting Revenue Outlook - Finimize
Why Integra LifeSciences (IART) Shares Are Sliding Today - Yahoo Finance
Integra LifeSciences (IART) Reports Strong Q3 Despite Supply Cha - GuruFocus
Integra LifeSciences stock hits 52-week low at 11.05 USD - Investing.com
Will Integra LifeSciences Holdings Corporation (IL3) stock gain from lower interest ratesEarnings Recap Report & Consistent Return Strategy Ideas - newser.com
Earnings call transcript: Integra LifeSciences Q3 2025 beats EPS expectations - Investing.com
Integra LifeSciences Q3 Loss Narrows; Cuts FY25 Revenue Guidance; Stock Up - Nasdaq
Integra LifeSciences Holdings C (IART) Q3 FY2025 earnings call transcript - Yahoo Finance
Integra LifeSciences Q3 Adj. EPS Tops Estimates, But Revenues Miss - Nasdaq
Integra LifeSciences Slashes FY25 OutlookUpdate - Nasdaq
Integra LifeSciences (IART) Q3 Earnings Beat Estimates - Yahoo Finance
Integra LifeSciences beats on earnings despite revenue miss - Investing.com
Integra Lifesciences Q3 2025 Earnings: Adjusted EPS of $0.54 Sur - GuruFocus
Integra LifeSciences (IART) Reports Q3 Revenue Below Expectations - GuruFocus
Integra LifeSciences Reports Third Quarter 2025 Financial Results - TradingView
IART furnishes Q3 2025 results with GAAP-to-non-GAAP reconciliations - Stock Titan
Integra LifeSciences (NASDAQ:IART) Misses Q3 Sales Expectations - Yahoo Finance
Integra Lifesciences Holdings Corp (IART) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Integra Lifesciences Holdings Corp 주식 (IART) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 11 '25 |
Option Exercise |
0.00 |
2,356 |
0 |
4,391 |
| Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '25 |
Option Exercise |
0.00 |
1,180 |
0 |
2,359 |
| Schwartz Eric | EVP, Chief Legal Officer & Sec |
Dec 03 '24 |
Sale |
24.59 |
4,070 |
100,102 |
59,511 |
1.84%
0.40%
자본화:
|
볼륨(24시간):